Formuepleje A/S’s Hologic HOLX Stock Holding History

Formuepleje A/S’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,498	Closed	-$634K	–	78
2021 Q2	$634K	Buy	9,498 +766	+9%	+$51.2K	0.02%	86
2021 Q1	$649K	Buy	8,732 +3,942	+82%	+$299K	0.02%	80
2020 Q4	$349K	Sell	4,790 -410	-8%	-$28.9K	0.01%	74
2020 Q3	$346K	Buy	5,200 +75	+1%	+$4.75K	0.02%	65
2020 Q2	$292K	Buy	+5,125	New	+$251K	0.01%	68

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Formuepleje A/S's HOLX Position: Q3 2021 in Review

Formuepleje A/S sold out of Hologic (HOLX) in Q3 2021, closing a stake of 9,498 shares — an estimated $634K sold.

Formuepleje A/S first reported a position in HOLX in Q2 2020 and held it in 5 quarters. The position peaked at $649K in Q1 2021. 644 funds tracked by Wall St. Rank hold HOLX as of Q3 2021.

Formuepleje A/S reported no remaining Hologic position as of Q3 2021 after selling out during the quarter.
Formuepleje A/S sold 9,498 Hologic shares in Q3 2021, an estimated $634K.
Formuepleje A/S first reported a position in Hologic in Q2 2020 and held it in 5 quarters.
Formuepleje A/S's Hologic position peaked at $649K in Q1 2021.
644 funds tracked by Wall St. Rank held Hologic as of Q3 2021.

Based on Formuepleje A/S's 13F filing for Q3 2021, filed 27 Aug 2026.